Table 1.
Receptor family | Agonists | Antagonists | CR type |
---|---|---|---|
IL-1 family | |||
IL-1R1 | IL-1α, IL-1β | IL-1Ra | Type 2 |
IL-1R2 | |||
IL-18 | IL-18, IL-37 | ||
IL-33R | IL-33 | ||
IL-36R | IL-36α, IL-36β, IL-36γ | IL-36Ra | |
IL-2 family | |||
IL-2R | IL-2 | IL-1Ra | Type 1 |
IL-4R1 | IL-4 | ||
IL-4R2 | IL-13, IL-4 | ||
IL-7R | IL-7 | ||
IL-9R | IL-2 | IL-1Ra | |
IL-13Rα2 | |||
IL-15R | IL-15 | ||
IL-21R | IL-21 | ||
IL-3 family | |||
IL-3R | IL-3 | Type 1 | |
IL-5R | IL-5 | ||
GM-CSFR | G-CSF, GM-CSF | ||
IL-3α | IL-3 | ||
IL-5Rα | GM-CSF | ||
GM-CSFRα | GM-CSF | ||
IL-6 family | |||
IL-6R | IL-6 | Type 1 | |
IL-11R | IL-11 | ||
IL-27R | IL-27 | ||
IL-31R | IL-31 | ||
IL-6Rα | IL-6 | ||
IL-10 family | |||
IL-10R | IL-10 | Type 2 | |
IL-20R | IL-19 | ||
IL-22Rα/20β | IL-20 | ||
IL-22Rα/10β | IL-22 | ||
IFN-λ | IFN-λ1, IFN-λ2, IFNλ3 | ||
IL-12 family | |||
IL-12R | IL-12 | A/IL-12B | Type 1 |
IL-23R | IL-12B/IL-23 | ||
IL-13 family | |||
IL-3R | IL-3 | Type 1 | |
IL-5R | IL-5 | ||
GM-CSFR | c-CSF, GM-CSF | ||
IL-3α | IL-3 | ||
IL-5α | IL-5 | ||
GM-CSFRα | |||
IL-17 family | |||
IL-17RA | IL-17A/IL-17F | Type 2 | |
IL-17RB | IL-17B | ||
IL-17RC | IL-17C | ||
IL-17RD | |||
IL-17RE | IL-17E | ||
IL-25 | IL-17B | ||
TNF family | |||
TNFR1 | TNF | ||
TNFR2 | TNF | ||
IFN family | |||
IFN-R, type 1 | IFN-α, IFN-β, IFN-κ, IFN-ω | ||
IFN-R, type 2 | IFN-γ |
IL-1R type 2 is decoy receptor and binds IL-1α, IL-1β, and IL-receptor antagonist.
IL-1R family: possess immunoglobulin-like extracellular domains and an intracellular toll/IL-1R domain.
IL-2R: both α and β subunits bind ligand.
IL-6R: Ras/Raf/MAPK, PI 3 kinase/PKB.
IL-10: family of heterodimers.
IL-13R and IL-22Rα: there are also decoy receptors that bind IL-13 and IL-22.
IL-17 family: 6 ligands and 5 receptors.
Symbols α and β.
Heterodimers: IL-12A/IL-12B; IL-12B/IL-23.
Ra, receptor antagonist; TNF, tumor necrosis factor.